Bora CDMO Bora CDMO

X

CAS 144689-93-0 manufacturers and suppliers on PharmaCompass

PharmaCompass
144689-93-0
Also known as: 144689-93-0, Ethyl 4-(1-hydroxy-1-methylethyl)-2-propylimidazole-5-carboxylate, 4-(1-hydroxy-1-methylethyl)-2-propyl-1h-imidazole-5-carboxylic acid ethyl ester, Ethyl 4-(2-hydroxypropan-2-yl)-2-propyl-1h-imidazole-5-carboxylate, Ethyl 5-(2-hydroxypropan-2-yl)-2-propyl-1h-imidazole-4-carboxylate, Ethyl 4-(1-hydroxy-1-methylethyl)-2-propyl-1h-imidazole-5-carboxylate
Molecular Formula
C12H20N2O3
Molecular Weight
240.30  g/mol
InChI Key
KZBJJAFGNMRRHN-UHFFFAOYSA-N

1 2D Structure

144689-93-0

2 Identification
2.1 Computed Descriptors
2.1.1 IUPAC Name
ethyl 5-(2-hydroxypropan-2-yl)-2-propyl-1H-imidazole-4-carboxylate
2.1.2 InChI
InChI=1S/C12H20N2O3/c1-5-7-8-13-9(11(15)17-6-2)10(14-8)12(3,4)16/h16H,5-7H2,1-4H3,(H,13,14)
2.1.3 InChI Key
KZBJJAFGNMRRHN-UHFFFAOYSA-N
2.1.4 Canonical SMILES
CCCC1=NC(=C(N1)C(C)(C)O)C(=O)OCC
2.2 Synonyms
2.2.1 Depositor-Supplied Synonyms

1. 144689-93-0

2. Ethyl 4-(1-hydroxy-1-methylethyl)-2-propylimidazole-5-carboxylate

3. 4-(1-hydroxy-1-methylethyl)-2-propyl-1h-imidazole-5-carboxylic Acid Ethyl Ester

4. Ethyl 4-(2-hydroxypropan-2-yl)-2-propyl-1h-imidazole-5-carboxylate

5. Ethyl 5-(2-hydroxypropan-2-yl)-2-propyl-1h-imidazole-4-carboxylate

6. Ethyl 4-(1-hydroxy-1-methylethyl)-2-propyl-1h-imidazole-5-carboxylate

7. 1h-imidazole-4-carboxylic Acid,5-(1-hydroxy-1-methylethyl)-2-propyl-,ethyl Ester

8. Mfcd07787565

9. Ethyl 4-(2-hydroxy-2-propyl)-2-propyl-1h-imidazole-5-carboxylate

10. Ec 604-434-7

11. Schembl987234

12. Dtxsid40441791

13. Bcp12023

14. Zinc21298029

15. Akos015856335

16. Am84409

17. Ds-0283

18. Ex-a3316-3

19. 1h-imidazole-5-carboxylic Acid, 4-(1-hydroxy-1-methylethyl)-2-propyl-, Ethyl Ester

20. Sy021273

21. Cs-0131776

22. E0976

23. Ft-0647781

24. 689h930

25. A808262

26. Q-200401

27. Ethyl 5-(2-hydroxy-2-propanyl)-2-propyl-1h-imidazole-4-carboxylate

28. Ethyl-4-(1-hydroxy-1-methylethyl)-2-propylimidazole-5-carboxylate

29. Ethyl4-(1-hydroxy-1-methylethyl)-2-propylimidazole-5-carboxylate

30. 2-propyl-4-(1-hydroxy-1-methylethyl)-1h-imidazole-5-carboxylic Acid Ethyl Ester

31. 2-propyl-5-(1-hydroxy-1-methylethyl)-3h-imidazole-4-carboxylic Acid Ethyl Ester

32. 4-(1-hydroxy-1-methylethyl)-2-propyl Imidazol-5-carboxylic Acid Ethyl Ester

33. 4-(2-hydroxy-2-propyl)-2-propyl-1h-imidazole-5-carboxylic Acid Ethyl Ester

34. 5-(1-hydroxy-1-methyl-ethyl)-2-propyl-1h-imidazole-4-carboxylic Acid Ethyl Ester

35. Olmesartan Impurity (ethyl 4-(1-hydroxy-1-methylethyl)-2- Propyl-imidazole-5-carboxylate)

36. 3-ethyl-5-(1-hydroxy-1-methyl-ethyl)-2-propyl-imidazole-4-carboxylate;olmesartan Impurity 2

2.3 Create Date
2006-10-25
3 Chemical and Physical Properties
Molecular Weight 240.30 g/mol
Molecular Formula C12H20N2O3
XLogP31.5
Hydrogen Bond Donor Count2
Hydrogen Bond Acceptor Count4
Rotatable Bond Count6
Exact Mass240.14739250 g/mol
Monoisotopic Mass240.14739250 g/mol
Topological Polar Surface Area75.2 Ų
Heavy Atom Count17
Formal Charge0
Complexity269
Isotope Atom Count0
Defined Atom Stereocenter Count0
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Covalently Bonded Unit Count1
Flag India
Digital Content Digital Content
144689-93-0
Malladi Drugs & Pharmaceuticals Ltd was founded in 1980 by microbiologist Mr. M L N Sastry. Within a few ...
Malladi Drugs & Pharmaceuticals Ltd was founded in 1980 by microbiologist Mr. M L N Sastry. Within a few years, Malladi established itself as a leader in manufacturing ephedrine and pseudoephedrine salts. Today, it is the leading manufacturer of APIs in the cough and cold segment. It also has a dominant presence in several therapeutic segments like antihistamines, anti-convulsants, anti-depressants and anxiolytics (CNS). Malladi exports its products to around 60 countries and over 85% of its revenue is generated from exports. Its manufacturing facilities have been approved by the FDA, EDQM, KFDA, TGA and various other regulatory agencies.
Malladi Company Banner

RDD 2024

Not Confirmed

envelop Contact Supplier
Flag India
Digital Content Digital Content
144689-93-0
Aarti Pharmalab, earlier the pharma division of Aarti Industries, is a leading Indian manufacturer of API...
Aarti Pharmalab, earlier the pharma division of Aarti Industries, is a leading Indian manufacturer of APIs. It has dedicated facilities to manufacture HPAPIs, corticosteroids, cytotoxic & oncology products. It has 2 R&D centers & 3 cGMP plants successfully audited by the USFDA, EUGMP, EDQM, KFDA & COFEPRIS. It also offers CDMO services for generic APIs & NCEs, intermediates & key building blocks.

Note: None of the products will be supplied to countries in which this could be in conflict with existing patents. Further, any products under patent will be offered for R&D purposes only. However, the final responsibility lies with the buyer.

Flag India
Digital Content Digital Content
URL Supplier Web Content
144689-93-0
Ocimum Labs was founded in 2018 and started its R&D activities with a cutting-edge facility. The Hyderaba...
Ocimum Labs was founded in 2018 and started its R&D activities with a cutting-edge facility. The Hyderabad-based firm focuses on process research and development, with a particular emphasis on choosing an API portfolio with a wide range of applications for the global pharma market. It provides a wide variety of integrated products and services. By offering timely and high-quality support, Ocimum Labs hopes to become a strategic partner to global pharma firms and deliver high-quality, cost effective key starting materials, intermediates and APIs. It intends to build a manufacturing facility with a 230KL capacity in Visakhapatnam, India.
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Flag India
Digital Content Digital Content
144689-93-0
Sigmak Lifesciences is a leading contract manufacturer, merchant exporter, & distributor of pharmaceutica...
Sigmak Lifesciences is a leading contract manufacturer, merchant exporter, & distributor of pharmaceutical APIs & Fine Chemicals. We excel in Contract Manufacturing, covering a wide spectrum of intermediates, including advance intermediates, cGMP, & non-GMP intermediates. We represent GMP and WHO-certified manufacturers of APIs & advanced intermediates, offering Distribution & Agency services with rigorous selection processes & regular audits to guarantee top-quality products. Moreover, our global Strategic Sourcing capabilities provide high-quality ingredients & performance chemicals to the Pharmaceuticals & Specialty Chemical Industries.
Sigmak Lifesciences CB

RDD 2024

Not Confirmed

envelop Contact Supplier
Flag India
Digital Content Digital Content
URL Supplier Web Content
144689-93-0
Believe pharma is one of the leading manufacturers of APIs and its intermediates with multi-dimensional b...
Believe pharma is one of the leading manufacturers of APIs and its intermediates with multi-dimensional business activities. The company maintain a high standard of quality in compliance with GMP and GLP for its products manufactured at our premises and meet the regulatory requirement of our customer. We have FDA approved Quality control lab and powder processing area.
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Flag China
Digital Content Digital Content
URL Supplier Web Content
144689-93-0
Jiangsu Zhongbang Pharmaceutical Co., Ltd. is a wholly-owned subsidiary of Red Sun Group. Company has bee...
Jiangsu Zhongbang Pharmaceutical Co., Ltd. is a wholly-owned subsidiary of Red Sun Group. Company has been founded since 2001 and occupied 100,000m2. Company has 80 million RMB registered capital and plan to have a total investment of 200 million RMB. Company has 168 employees at present, in which there are 34 employees with Bachelor’s Degree or above, 12 employees with Master’s Degree or above, each kind of professional talents have occupied over 60% of the total employees. Company has got China GMP certificate since 2006 and currently has one GMP plant for API and one GMP plant for solid finished products. There are two production lines in API GMP plants with annual capacity of 50 tons API. There are equipment for tablets, capsules and granules in solid finished products. Company has set up qualified documentation systems according to China GMP and Europe and USA C-GMP. Company has the plan to pass COS and FDA authentication both around 2014. Company also pays serious attention on public welfare and concerns on green energy conservation and environmental protection undertaking.
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Flag India
Digital Content Digital Content
URL Supplier Web Content
144689-93-0
Smilax Laboratories Limited is a research-driven, vertically integrated pharmaceutical company manufactur...
Smilax Laboratories Limited is a research-driven, vertically integrated pharmaceutical company manufacturing Active Pharmaceutical Ingredients, API Intermediates and NDDS/Pellets for the generics market across the world. Set up in 2005, Smilax has emerged a reliable supplier of generic products in the global market today. Set up in 2005, Smilax has emerged a reliable supplier of generic products in the global market today.Set up in 2005, Smilax has emerged a reliable supplier of generic products in the global market today. Smilax manufactures APIs and API Intermediates at its state-of-the-art manufacturing facilities located at Hyderabad, Telangana and Visakhapatnam, Andhra Pradesh, India. Supported by a highly qualified and competent technical team, and endowed with strengths in research and development, Smilax continues to expand its presence in the world of pharmaceuticals.
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Flag India
Digital Content Digital Content
URL Supplier Web Content
144689-93-0
Syngenesis Chemscience Private Limited founded in 2017. Headquarters in Nashik, Maharashtra, India. We su...
Syngenesis Chemscience Private Limited founded in 2017. Headquarters in Nashik, Maharashtra, India. We support customers located across India and Globe. Our state-of-the-art and Manufacturing facility is located at Nashik, Maharashtra, India. Syngenesis Chemscience Private Limited is committed to provide outstanding customer service and high quality pharmaceuticals Drug Intermediates and Drug Substances (Active Pharmaceuticals Ingredients) in a timely manner to meet customer requirements. We are manufacturer of many pharmaceuticals Drug Intermediates and Drug Substances (Active Pharmaceuticals Ingredients) in a timely manner.
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Flag India
Digital Content Digital Content
URL Supplier Web Content
144689-93-0
VIDGAS aims to provide our pharmaceutical, Bio pharma, Agrochemical, Food and Fine chemical customers wit...
VIDGAS aims to provide our pharmaceutical, Bio pharma, Agrochemical, Food and Fine chemical customers with the highest quality SFC and HPLC purification and isolation solutions that market has to offer. With our 25 years of HPLC experience, we are able to provide variety of products with custom tailored answers for even most difficult separations. Our team of professional Chromatographers is available to assist in HPLC and SFC methods development solutions. Here at VIDGAS we are constantly innovating and pursuing the limits of HPLC and SFC.
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Flag China
Digital Content Digital Content
URL Supplier Web Content
144689-93-0
Zhejiang Huahai Pharmaceuticals Co., Ltd.was initially founded in 1989, and the company's stock was succe...
Zhejiang Huahai Pharmaceuticals Co., Ltd.was initially founded in 1989, and the company's stock was successfully listed in Shanghai Stock Exchange in March, 2003. Huahai Pharmaceuticals, a large scaled modern pharmaceutical group that integrates fomulations, APIs(Active Pharmaceutical Ingredients) and intermediates, is developing both domestic and international markets, and performing parallel development of science, industry and commerce. With a total asset of 1,900 million yuan, the company has 11branches (subsidiaries) in the United States, Shanghai, Hangzhou, and Linhai.
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Flag China
Digital Content Digital Content
URL Supplier Web Content
144689-93-0
Zhuhai Rundu Pharmaceutical Co., Ltd. is a modern scientific and technological pharmaceutical enterprise ...
Zhuhai Rundu Pharmaceutical Co., Ltd. is a modern scientific and technological pharmaceutical enterprise integrating drug research and development, production, and sales. It is located in Jinwan District, Zhuhai City, Guangdong Province. It was established in 1999. On January 5, 2018, the company was listed on the Shenzhen Stock Exchange (stock abbreviation: Rundu; stock code: 002923). The company's main business is the research and development, production, and sales of chemical-pharmaceutical preparations, chemical raw materials, and pharmaceutical intermediates. field.
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty
Post Enquiry
POST ENQUIRY